"Центральна міська клінічна лікарня - сучасний багатопрофільний медичний заклад, в якому надається спеціалізована та вузькоспеціалізована медична допомога. Діагностика У нашій лікарні пацієнти проходять точну діагностику завдяки сучасному обладнанню, лабораторним дослідженням та професіоналізму медичних працівників. Лікування Медичний заклад надає широкий спектр амбулаторного та стаціонарного лікування: комфортні палати, нове обладнання та кваліфікований персонал. Реабілітація Ми допомагає пацієнтам якомога швидше повернутися у звичний ритм життя завдяки відповідному реабілітаційному лікуванні. «Наше завдання – досягнути найвищої якості надання медичної допомоги. Здорова нація має майбутнє»"

During the past decade, Ivano-Frankivsk City Central Clinical Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 4 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 3 clinical trials were completed. i.e. 27.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ivano-Frankivsk City Central Clinical Hospital" #1 sponsor was "Pfizer" with 4 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored, "Actelion" with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ivano-Frankivsk City Central Clinical Hospital" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ivano-Frankivsk City Central Clinical Hospital" are "Ulcerative Colitis" (3 trials), "COVID-19" (2 trials), "Coronavirus Disease (COVID-19)" (2 trials), "Breast Cancer" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Ivano-Frankivsk City Central Clinical Hospital" in a lesser frequency.

Most popular intervention types in "Ivano-Frankivsk City Central Clinical Hospital" are "Drug" (13 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Molnupiravir" (2 trials), "PF-07321332" (2 trials), "Ritonavir" (2 trials) and "Cetuximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ivano-Frankivsk City Central Clinical Hospital" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Ivano-Frankivsk City Central Clinical Hospital". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ivano-Frankivsk City Central Clinical Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ivano-Frankivsk City Central Clinical Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".